ArriVent BioPharma, Inc. (AVBP) KPIs and segments
AVBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.69−0.87 (-7.53%)
Close on Nov 17, 2026Market cap $527.10MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive ArriVent BioPharma's business
Coming soon
This tab will track the numbers specific to ArriVent BioPharma's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?